NovaBay Pharma (NBY) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $0.08 --0%
Revenue Growth %: -14.6%
Financial Fact:
Other revenues: 176K
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: -14.6%
Financial Fact:
Other revenues: 176K
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q2 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $1.01 million versus the consensus estimate of $610 thousand.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Senesco Technologies, Inc. (SNT) Reports Q1 EPS of $0.02
- MetroCity Bankshares, Inc. (MCBS) Tops Q1 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
